Literature DB >> 11896817

The clinical relevance of epithelial dysplasia in the surgical margins of tongue and floor of mouth squamous cell carcinoma: an analysis of 37 patients.

M Weijers1, G B Snow, P D Bezemer, J E van der Wal, I van der Waal.   

Abstract

BACKGROUND: The clinical relevance of the presence of epithelial dysplasia in the margins of surgically removed oral squamous cell carcinoma is still unclear.
METHOD: In a retrospective study, the presence of mild or moderate epithelial dysplasia in the surgical margins of tongue and floor of mouth squamous cell carcinoma was examined histologically. Patients with tumor cells within 0.5 cm of the surgical margins were excluded. Also patients with severe dysplasia were excluded, as this is usually regarded as carcinoma in situ. Patients that received postoperative irradiation were also excluded. Only patients who completed a follow-up period of five years were included. All together, a total number of 37 patients fulfilled the inclusion criteria.
RESULTS: Epithelial dysplasia was observed in 7 out of the 37 patients. Five of these patients, and two of the 30 patients with no dysplasia, had a local recurrence (P < 0.01).
CONCLUSION: The presence of mild or moderate epithelial dysplasia in the margins of surgically removed oral squamous cell carcinoma carries a significant risk for the development of local recurrence. However, it should be noted that this study was of a retrospective nature and that the group of patients with epithelial dysplasia in the surgical margins was rather small. On the other hand, the inclusion criteria were somewhat strict, by limiting the oral subsite to tongue/floor of mouth, by excluding patients in whom tumors cell were found within 0.5 cm of the surgical margins and by excluding patients who received postoperative radiotherapy, amongst others.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11896817     DOI: 10.1034/j.1600-0714.2002.310103.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  10 in total

1.  Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients.

Authors:  Waseem Jerjes; Tahwinder Upile; Aviva Petrie; Andrew Riskalla; Zaid Hamdoon; Michael Vourvachis; Kostas Karavidas; Amrita Jay; Ann Sandison; Gareth J Thomas; Nicholas Kalavrezos; Colin Hopper
Journal:  Head Neck Oncol       Date:  2010-04-20

2.  Dysplasia at the margin? Investigating the case for subsequent therapy in 'low-risk' squamous cell carcinoma of the oral tongue.

Authors:  Dennis M Sopka; Tianyu Li; Miriam N Lango; Ranee Mehra; Jeffrey Chang-Jen Liu; Barbara Burtness; Douglas B Flieder; John A Ridge; Thomas J Galloway
Journal:  Oral Oncol       Date:  2013-09-17       Impact factor: 5.337

3.  A prospective study of prognostic factors for recurrence in early oral tongue cancer.

Authors:  Prashant Sharma; S V Shah; Charu Taneja; Ashok M Patel; Mahesh D Patel
Journal:  J Clin Diagn Res       Date:  2013-11-10

4.  SUOX is negatively associated with multistep carcinogenesis and proliferation in oral squamous cell carcinoma.

Authors:  Ken Nakamura; Jun Akiba; Sachiko Ogasawara; Yoshiki Naito; Masamichi Nakayama; Yushi Abe; Jingo Kusukawa; Hirohisa Yano
Journal:  Med Mol Morphol       Date:  2017-12-26       Impact factor: 2.309

5.  Molecular diagnosis of minimal residual disease in head and neck cancer patients.

Authors:  A Peggy Graveland; Boudewijn J M Braakhuis; Simone E J Eerenstein; Remco de Bree; Elisabeth Bloemena; Michiel de Maaker; Michiel W M van den Brekel; Frederike Dijk; Wilma E Mesker; Hans J Tanke; C Rene Leemans; Ruud H Brakenhoff
Journal:  Cell Oncol (Dordr)       Date:  2012-09-04       Impact factor: 6.730

6.  Fluorescence molecular imaging for identification of high-grade dysplasia in patients with head and neck cancer.

Authors:  Shayan Fakurnejad; Stan van Keulen; Naoki Nishio; Myrthe Engelen; Nynke S van den Berg; Guolan Lu; Andrew Birkeland; Fred Baik; A Dimitrios Colevas; Eben L Rosenthal; Brock A Martin
Journal:  Oral Oncol       Date:  2019-08-12       Impact factor: 5.337

7.  Lugol's iodine identifies dysplastic tissue in precancerous lesions: A clinical trial.

Authors:  Shereen Fatima; Rajarshi Basu; Neelakamal H Hallur
Journal:  Ann Maxillofac Surg       Date:  2016 Jul-Dec

8.  p53-positive expression in dysplastic surgical margins is a predictor of tumor recurrence in patients with early oral squamous cell carcinoma.

Authors:  Xi-Hu Yang; Liang Ding; Yong Fu; Sheng Chen; Lei Zhang; Xiao-Xin Zhang; Xiao-Feng Huang; Zhan-Yi Lu; Yan-Hong Ni; Qin-Gang Hu
Journal:  Cancer Manag Res       Date:  2019-02-13       Impact factor: 3.989

Review 9.  Epithelial Dysplasia at Excision Margins of Oral Squamous Cell Carcinoma: A Review on Relationship to Clinicopathological Parameters and Prognosis.

Authors:  Nimna H Senarath; Primali R Jayasooriya; Bogahawatte S M S Siriwardena; Wanninayake M Tilakaratne
Journal:  Asian Pac J Cancer Prev       Date:  2021-08-01

10.  LIHNCS - Lugol's iodine in head and neck cancer surgery: a multicentre, randomised controlled trial assessing the effectiveness of Lugol's iodine to assist excision of moderate dysplasia, severe dysplasia and carcinoma in situ at mucosal resection margins of oral and oropharyngeal squamous cell carcinoma: study protocol for a randomised controlled trial.

Authors:  James A McCaul; James A Cymerman; Stuart Hislop; Chris McConkey; Jeremy McMahon; Hisham Mehanna; Richard Shaw; David N Sutton; Janet Dunn
Journal:  Trials       Date:  2013-09-24       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.